Devalingam Mahalingam in Chicago, Illinois

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2000
The Primary Medical Specialty for Devalingam Mahalingam is listed as: Hematology/oncology
Approximate Years of Experience: 24
PAC (PECOS ID)#: 1052465267
NPI #: 1164650859
NPI Created On: 07/01/2009
NPI Last Updated Listed as: 07/21/2022
Primary Taxonomy Code: 207R00000X
License Number:
P1668
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Collection of blood specimen from a completely implantable venous access device
2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
3. Infusion into a vein for therapy, prevention, or diagnosis
4. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
6. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
7. Application of on-body injector for injection under skin
8. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
9. Infusion of different chemotherapy drug or substance into a vein
10. Infusion of chemotherapy into a vein up to 1 hour
11. Infusion of chemotherapy into a vein
12. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
13. New patient office or other outpatient visit, typically 60 minutes
14. New patient office or other outpatient visit, typically 60 minutes
15. Established patient office or other outpatient, visit typically 25 minutes
16. Established patient office or other outpatient, visit typically 25 minutes
17. Established patient office or other outpatient, visit typically 40 minutes
18. Established patient office or other outpatient, visit typically 40 minutes
19. Physician telephone patient service, 21-30 minutes of medical discussion
20. Injection, denosumab, 1 mg